You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MAZE Exercise Disclosure
Bernstein Harold · SEC Form 4 · Filed Sep 3, 2026
Exercise
Calculated transaction value
$0
Bernstein Harold President, R&d & CMO
MAZE
Maze Therapeutics
MAZE
Transaction date
Sep 1, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 2 days later
MAZE daily price context
Close on/before transaction
$26.53
Sep 1, 2026
First close after public filing
$26.21
Sep 4, 2026
30-day return after filing
+0.84%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 20,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002050172-26-000032
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$593.7K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Maze Therapeutics, Inc. MAZE | Exercise | Sep 1, 2026 | $168.19K |
| Maze Therapeutics, Inc. MAZE | Sale | Sep 1, 2026 | $425.51K |
| Maze Therapeutics, Inc. MAZE Current | Exercise | Sep 1, 2026 | $0 |
| Maze Therapeutics, Inc. MAZE | Exercise | Sep 1, 2026 | $0 |
| Maze Therapeutics, Inc. MAZE | Exercise | Sep 1, 2026 | $0 |